Kyndryl Holdings is trading at $13.28 (+5.80%) after no clear company-specific catalyst was identified for August 24, 2026.
- Recent company items—including the August 19 AI innovation award, August 14 executive equity awards, and August 10 healthcare acquisition agreement—predate the move and do not clearly explain it.
- Broader indexes are lower pre-market, so the gain is not confirmed as market-driven.